采用无PCR步骤的全新制备方法加快全基因组测序
Rady儿童基因组医学研究所使用Illumina DNA PCR-Free Prep试剂盒和NovaSeq 6000基因测序仪,为罕见遗传病患儿打造了一个诊断时间可能破纪录的工作流程。
释放无限可能
可扩展、灵活的测序,适用于各种样本类型、方法和应用
NovaSeq 6000基因测序仪能够高效、经济地执行全基因组测序(WGS)。采用精简的工作流程,其可调输出可在双流动槽模式下生成多达6 Tb和200亿条read。该系统只需不到1天就能完成一组3个样本的测序,只需2天左右的时间就能完成多达48个基因组的测序,可实现更全面的覆盖。
高性能、快速、无需PCR的集成式工作流程,适用于人类全基因组测序或肿瘤–正常测序等要求灵敏度的应用。
快速、集成的工作流程,适用于各种应用,包括全人类基因组、扩增子、质粒和微生物基因组的测序。
即用型试剂盒,包括在NovaSeq 6000基因测序仪上进行可靠的高通量测序所需的试剂卡盒、流动槽和缓冲液。提供多种测序输出和读长选项。
Representing less than 2% of the genome, whole-exome sequencing is a cost-effective alternative to whole-genome sequencing. The NovaSeq 6000 System offers sequencing of up to 500 exomes in a single run using a dual S4 flow cell.
Illumina DNA Prep with Enrichment
Fast, integrated DNA-based library preparation and enrichment combining on-bead tagmentation with a single hybridization protocol for targeted sequencing applications.
NovaSeq 6000 Reagent Kits v1.5
Ready-to-use reagent kits include the reagent cartridge, flow cell, and buffer for reliable, high-throughput sequencing on the NovaSeq 6000 System. Multiple sequencing output and read length options available.
Aligns and calls variants from FASTQ, BAM, or CRAM files, outputting BAM and VCF files.
Detect coding and multiple forms of noncoding RNA in normal or low-quality samples. The NovaSeq 6000 System offers sequencing of up to 400 transcriptomes in a single run using a dual S4 flow cell.
Illumina Stranded Total RNA Prep with Ribo-Zero Plus or Ribo-Zero Plus Microbiome
Rapid library preparation from a broad range of sample types for studying the coding and noncoding transcriptome with unparalleled study flexibility.
NovaSeq 6000 Reagent Kits v1.5
Ready-to-use reagent kits include the reagent cartridge, flow cell, and buffer for reliable, high-throughput sequencing on the NovaSeq 6000 System. Multiple sequencing output and read length options available.
看看NovaSeq 6000基因测序仪能够做些什么
Rady儿童基因组医学研究所使用Illumina DNA PCR-Free Prep试剂盒和NovaSeq 6000基因测序仪,为罕见遗传病患儿打造了一个诊断时间可能破纪录的工作流程。
基于云的DRAGEN二级分析使GeneDx能够采用NovaSeq 6000系统进行高通量全基因组测序,并能够精确地鉴定变异。
GenOMICC和Genomics England启动了大型测序研究,旨在揭示COVID-19易感人群的遗传因素。